Sunday, October 18, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $343.46 +0.43%
MSFT $529.05 -1.93%
GOOGL $340.59 -2.47%
AMZN $250.00 -1.87%
TSLA $354.72 -2.13%
META $709.33 -3.72%
NVDA $214.13 -1.43%
JPM $339.72 +1.25%
BTC $36.03 -0.93%
ETH $22.98 -1.71%
Latest Signing ceremony for contribution agreements between WHO and France Oct 17, 2024
AAPL
$343.46
▲ 0.43%
MSFT
$529.05
▼ 1.93%
GOOGL
$340.59
▼ 2.47%
AMZN
$250.00
▼ 1.87%
TSLA
$354.72
▼ 2.13%
META
$709.33
▼ 3.72%
NVDA
$214.13
▼ 1.43%
JPM
$339.72
▲ 1.25%

Top Stories

Markets →
All Markets Technology Economy Science Health Sports Entertainment Politics
The Guardian
TikTok agrees to $400m settlement to resolve US children’s privacy litigation
The DoJ sued TikTok and its former parent company in August 2024 for allegedly failing to protect children’s privacy and collecting their information⁠TikTok and its Chinese former parent company ByteDance on Friday agreed to a $400m settlement to resolve the US Department of Justice’s allegations that the short-form video app ⁠violated children’s online ⁠privacy.The justice ​department sued TikTok and ByteDance in 2024 for allegedly failing to protect children’s privacy and illegally collecting
general  Aug 21, 2026
The Guardian
‘Darth Vader’ comes out in favor of Flock cameras at San Diego city council meeting
The dark lord – or someone dressed like him – said the technology would aid the empire in tracking ‘rebel scum’A man dressed as Darth Vader appeared to poke fun at San Diego officials for using Flock Safety automated license plate readers at a city council meeting this week, a stunt that comes as the company faces growing backlash linked to spying concerns.The man, whose real identity remains unknown, masqueraded on Thursday as the Star Wars villain at a San Diego public safety committee meeting
general  Aug 21, 2026
Bloomberg Markets
Moderna, Merck Cancer Vax Gives Hope
Scientists are on the cusp of fulfilling a decades-long quest: to use vaccines to teach the immune system to spot and destroy cancer cells. News that an mRNA cancer vaccine developed by Merck & Co. and Moderna Inc. kept melanoma from returning in a large, late-stage trial marks a critical next chapter for a technology beleaguered by post-pandemic political backlash and years of false starts before then. Bloomberg Opinion Columnist Lisa Jarvis writes "Moderna and Merck's Cancer Vaccine Is a Marve
business  Aug 21, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free